Does RIBOCICLIB Cause Mucosal inflammation? 171 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 171 reports of Mucosal inflammation have been filed in association with RIBOCICLIB (KISQALI). This represents 0.6% of all adverse event reports for RIBOCICLIB.
171
Reports of Mucosal inflammation with RIBOCICLIB
0.6%
of all RIBOCICLIB reports
17
Deaths
50
Hospitalizations
How Dangerous Is Mucosal inflammation From RIBOCICLIB?
Of the 171 reports, 17 (9.9%) resulted in death, 50 (29.2%) required hospitalization, and 4 (2.3%) were considered life-threatening.
Is Mucosal inflammation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 171 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOCICLIB Cause?
Neutropenia (3,585)
Nausea (3,404)
Fatigue (3,327)
Malignant neoplasm progression (2,468)
Death (2,452)
Vomiting (1,953)
Diarrhoea (1,830)
White blood cell count decreased (1,683)
Pain (1,637)
Metastases to bone (1,538)
What Other Drugs Cause Mucosal inflammation?
METHOTREXATE (3,352)
CYCLOPHOSPHAMIDE (2,535)
DOXORUBICIN (1,939)
VINCRISTINE (1,594)
ETOPOSIDE (1,591)
FLUOROURACIL (1,481)
RITUXIMAB (1,364)
CYTARABINE (1,337)
CAPECITABINE (1,262)
CARBOPLATIN (1,259)
Which RIBOCICLIB Alternatives Have Lower Mucosal inflammation Risk?
RIBOCICLIB vs RIBOFLAVIN
RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE
RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE
RIBOCICLIB vs RIFABUTIN
RIBOCICLIB vs RIFAMPICIN